NDT Pharmaceuticals, Inc. does not currently pay dividends.
What is NDT Pharmaceuticals, Inc.’s EPS estimate?
NDT Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NDT Pharmaceuticals, Inc. have?
NDT Pharmaceuticals, Inc. has 160,004,350 shares outstanding.
What happened to NDT Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NDT Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in NDTP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NDT Pharmaceuticals, Inc.
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.